Regorafenib is a drug used to treat advanced colorectal cancer, GIST, and HCC. It’s a multi-kinase inhibitor. It goes after things like VEGFR, TIE2, and a few other kinases.
The drug is presented in the form of 40 mg film-coated tablets, with the recommended daily dose being 160 mg, taken once daily for a period of 21 days within a 28-day cycle. These bottles hold 84 tablets each.
